BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36625449)

  • 1. The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis.
    Patrich T; Wang Y; Elshaikh MA; Zhu S; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Taunk NK; Chino J; Russo AL; Lea JS; Lee LJ; Albuquerque KV; Hathout L
    Am J Clin Oncol; 2023 Mar; 46(3):114-120. PubMed ID: 36625449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
    Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis of endometrial cancer patients with positive lymph nodes.
    Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
    Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Prophylactic Paraortic Lymph Node Irradiation Improve Outcomes in Women With Stage IIIC1 Endometrial Carcinoma?
    Yoon J; Fitzgerald H; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ; Hathout L
    Pract Radiat Oncol; 2022; 12(2):e123-e134. PubMed ID: 34822999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
    Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
    Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
    Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
    Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
    Polterauer S; Khalil S; Zivanovic O; Abu-Rustum NR; Hofstetter G; Concin N; Grimm C; Reinthaller A; Barakat RR; Leitao MM
    Obstet Gynecol; 2012 Jun; 119(6):1210-8. PubMed ID: 22617586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of quality of care on racial disparities in survival for endometrial cancer.
    Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
    Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
    J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.
    Ozen A; Falchook AD; Varia MA; Gehrig P; Jones EL
    Gynecol Oncol; 2015 Aug; 138(2):429-33. PubMed ID: 26024766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer.
    Feldman A; Chaugle S; Burmeister C; Munkarah A; Elshaikh MA
    Gynecol Obstet Invest; 2019; 84(3):283-289. PubMed ID: 30540995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.